Literature DB >> 157693

Ischemic heart disease secondary to amyloidosis of intramyocardial arteries.

R R Smith, G M Hutchins.   

Abstract

Among 108 patients with cardiac amyloidosis studied at autopsy between 1889 and 1977 there were 5 (4.6 percent) with severe occlusive amyloid deposits in intramyocardial arteries. The hearts of all five patients showed focal subendocardial ischemic injury, and the vessels supplying these areas had either complete or near complete luminal obliteration by amyloid. Clinically, four patients had congestive heart failure; one of these patients also had arrhythmias and one had angina pectoris. Neither the clinical nor the pathologic features of ischemic heart diseases could be attributed to disease of the epicardial coronary arteries. Amyloidosis of the intramyocardial arteries appears to be capable of producing localized areas of ischemic necrosis and may produce intractable congestive heart failure due to multiple areas of ischemic injury.

Entities:  

Mesh:

Year:  1979        PMID: 157693     DOI: 10.1016/0002-9149(79)90389-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Rest-redistribution thallium-201 myocardial scintigraphic study in cardiac amyloidosis.

Authors:  K Kodama; M Hamada; T Kuwahara; M Nakamura; Y Shigematsu; K Hiwada; T Iwata; Y Hoshii; T Ishihara
Journal:  Int J Card Imaging       Date:  1999-10

2.  The value of conventional echocardiographic and tissue doppler imaging in the diagnosis of cardiac amyloidosis.

Authors:  Li Zhang; Mingxing Xie; Xinfang Wang; Yali Yang; Junhong Huang; Ming Cheng; Feixiang Xiang; Qing Lü
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

Review 3.  Microvascular dysfunction in infiltrative cardiomyopathies.

Authors:  Ornella Rimoldi; Francesco Maranta
Journal:  J Nucl Cardiol       Date:  2017-07-11       Impact factor: 5.952

4.  Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis.

Authors:  Sharmila Dorbala; Divya Vangala; John Bruyere; Christina Quarta; Jenna Kruger; Robert Padera; Courtney Foster; Michael Hanley; Marcelo F Di Carli; Rodney Falk
Journal:  JACC Heart Fail       Date:  2014-07-09       Impact factor: 12.035

5.  Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.

Authors:  Hiromi Hashimura; Hatsue Ishibashi-Ueda; Yumiko Yonemoto; Keiko Ohta-Ogo; Taka-Aki Matsuyama; Yoshihiko Ikeda; Yoshiaki Morita; Naoaki Yamada; Hiroki Yasui; Hiroaki Naito
Journal:  Heart Vessels       Date:  2015-03-21       Impact factor: 2.037

Review 6.  Amyloid in the cardiovascular system: a review.

Authors:  I Kholová; H W M Niessen
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

7.  Impaired left ventricular diastolic filling in patients with familial amyloid polyneuropathy: a pulsed Doppler echocardiographic study.

Authors:  O Kinoshita; M Hongo; H Yamada; T Misawa; J Kono; S Okubo; S Ikeda
Journal:  Br Heart J       Date:  1989-02

8.  Primary cardiac amyloidosis in a young man presenting with angina pectoris.

Authors:  S Saltissi; P J Kertes; D G Julian
Journal:  Br Heart J       Date:  1984-08

9.  An unusual case of cardiac amyloidosis.

Authors:  Brian Garibaldi; David Zaas
Journal:  J Gen Intern Med       Date:  2007-04-20       Impact factor: 5.128

10.  The Use of Cardiac Resynchronization Therapy in Cancer Patients with Heart Failure.

Authors:  Anecita P Fadol; Elie Mouhayar; Cielito C Reyes-Gibby
Journal:  J Clin Exp Res Cardiol       Date:  2017-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.